Management of Hot Flashes in Post-Hysterectomy Women

Introduction to Treatment Options

The American College of Obstetricians and Gynecologists recommends estrogen-only therapy as the most effective treatment for hot flashes in women who have had a hysterectomy, reducing symptoms by 80-90% 1
Transdermal estrogen patches are preferred over oral estrogen due to lower thrombotic risk, as suggested by the North American Menopause Society 1, 2

The National Comprehensive Cancer Network recommends venlafaxine as a first-line non-hormonal option, starting at 37.5 mg daily and increasing to 75 mg after 1 week if needed, with a reduction in hot flash frequency and severity by 37-65% 3, 4, 1
Gabapentin is also recommended, with a dose of 900 mg/day in divided doses, reducing hot flash severity by approximately 46-49% and having no drug interactions or sexual dysfunction, as noted by the Annals of Oncology 3, 4, 1, 5, 6
Paroxetine is an alternative SSRI option, but should be avoided if the patient is taking tamoxifen due to strong inhibition of CYP2D6, as warned by the Annals of Oncology 5, 6

The clinical decision algorithm suggests using transdermal estrogen patches if there are no contraindications to estrogen, as recommended by the American College of Obstetricians and Gynecologists 1, 2
If estrogen is contraindicated but the patient is not on tamoxifen, venlafaxine or gabapentin should be chosen as first-line, considering gabapentin if sexual dysfunction is a concern and venlafaxine for faster onset, as suggested by the National Comprehensive Cancer Network and the Annals of Oncology 5, 6, 1, 3, 4

Regular follow-up is necessary to assess symptom control and side effects, as emphasized by the American College of Obstetricians and Gynecologists 2
Custom compounded bioidentical hormones should be avoided due to lack of safety and efficacy data, as warned by the North American Menopause Society 1, 2
Smoking cessation can help manage hot flashes, as suggested by the American College of Obstetricians and Gynecologists 2